These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23348588)

  • 1. TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.
    Keuper M; Wernstedt Asterholm I; Scherer PE; Westhoff MA; Möller P; Debatin KM; Strauss G; Wabitsch M; Fischer-Posovszky P
    Cell Death Dis; 2013 Jan; 4(1):e474. PubMed ID: 23348588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors.
    Zoller V; Funcke JB; Keuper M; Abd El Hay M; Debatin KM; Wabitsch M; Fischer-Posovszky P
    Cell Death Dis; 2016 Oct; 7(10):e2412. PubMed ID: 27735943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.
    Shlyakhtina Y; Pavet V; Gronemeyer H
    Cell Death Dis; 2017 Aug; 8(8):e3025. PubMed ID: 29048428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.
    Funcke JB; Zoller V; El Hay MA; Debatin KM; Wabitsch M; Fischer-Posovszky P
    FASEB J; 2015 Jul; 29(7):3065-75. PubMed ID: 25857555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
    Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
    J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone induces pancreatic β-cell apoptosis through upregulation of TRAIL death receptor.
    Suksri K; Semprasert N; Junking M; Kutpruek S; Limjindaporn T; Yenchitsomanus PT; Kooptiwut S
    J Mol Endocrinol; 2021 Aug; 67(3):95-106. PubMed ID: 34223821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.
    Dai X; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
    Exp Biol Med (Maywood); 2015 Jun; 240(6):760-73. PubMed ID: 25854879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.
    Kim HB; Kim MJ; Kim DY; Lee JW; Bae JH; Kim DW; Kang CD; Kim SH
    Mol Cancer; 2011 Apr; 10():46. PubMed ID: 21513580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
    Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
    Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance of human glioma cells to Apo2 ligand/TNF-related apoptosis-inducing ligand.
    Rieger J; Frank B; Weller M; Wick W
    Cell Physiol Biochem; 2007; 20(1-4):23-34. PubMed ID: 17595512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
    J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.
    Milani D; Zauli G; Rimondi E; Celeghini C; Marmiroli S; Narducci P; Capitani S; Secchiero P
    J Neurochem; 2003 Jul; 86(1):126-35. PubMed ID: 12807432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IG20 splice variants in TRAIL resistance.
    Prabhakar BS; Mulherkar N; Prasad KV
    Clin Cancer Res; 2008 Jan; 14(2):347-51. PubMed ID: 18223207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
    J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of paeoniflorin on tumor necrosis factor-α-induced insulin resistance and changes of adipokines in 3T3-L1 adipocytes.
    Kong P; Chi R; Zhang L; Wang N; Lu Y
    Fitoterapia; 2013 Dec; 91():44-50. PubMed ID: 23978582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin.
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Med Oncol; 2015 Apr; 32(4):133. PubMed ID: 25796504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.
    Omar HA; Arafa el-SA; Maghrabi IA; Weng JR
    Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):464-71. PubMed ID: 24401154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.